SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001385508-18-000096
Filing Date
2018-10-31
Accepted
2018-10-31 16:03:18
Documents
2
Period of Report
2018-10-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_154101618246702.html 3  
1 FORM 3 wf-form3_154101618246702.xml 3 1734
2 POWER OF ATTORNEY opiant_section16powerofatt.htm EX-24 2205
  Complete submission text file 0001385508-18-000096.txt   5625
Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address 919-678-6611
Collard Craig A (Reporting) CIK: 0001363558 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38193 | Film No.: 181150299

Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 1000 Metal Mining